NCT05713994 2025-03-25
CCGLC-001
Tongji Hospital
Recruiting
Clinical Trials
14 trialsNCT06592989 2025-01-10
A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Recruiting
NCT05717738 2024-06-13
CCGLC-008
Tongji Hospital
Recruiting
NCT05889949 2023-06-07
Microvascular Invasion for Guiding Treatment of Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma
Sun Yat-sen University
Unknown
NCT05596968 2022-10-27
The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD Positive AML After Allo-HSCT
Nanfang Hospital, Southern Medical University
Unknown
NCT05596981 2022-10-27
The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or Without Sorafenib Maintenance After Allo-HSCT
Nanfang Hospital, Southern Medical University
Unknown
NCT04788420 2022-06-01
Influence of Co-existing Mutations on Sorafenib Maintenance Therapy After Allo-HSCT for Patients With FLT3-ITD AML
Nanfang Hospital, Southern Medical University
Completed
NCT02973204 2021-04-28
Circulating Tumor Cells and Tumor DNA in HCC and NET
University of Aarhus
Completed
NCT04553458 2020-09-17
Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma
Sohag University
Completed
NCT04152356 2019-11-05
Combined Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma
Guangxi Medical University
Unknown
NCT01507740 2015-04-29
Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients
Medical University Innsbruck
Terminated
NCT01328223 2011-04-04
Study of Combined Sorafenib With Radiotherapy in Patients With Advanced Hepatocellular Carcinoma
China Medical University Hospital
Unknown
NCT01319942 2011-03-22
Combined Radiotherapy and Sorafenib in Patients With Hepatoma
China Medical University Hospital
Unknown
NCT01230697 2010-10-29
SORHORM
University of Turin, Italy
Unknown